跳至主要内容
临床试验/IRCT201204043836N4
IRCT201204043836N4已完成2 期

Prospective Randomized Trial of Esomeprazole versus Lansoprazole and Omeprazole Based Triple Therapy for H. Pylori Eradication in an Iranian Population

Jundishapour Ahvaz Uuniversity of Medical Science0 个研究点目标入组 300 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 60 years(—)
性别
All

入选标准

  • Patients with endoscopic evidence of peptic ulcer, non-ulcer dyspepsia, gastritis or acid reflux with confirmation H. Pylori, either by histology or a positive Urease test will enroll in the study.
  • Exclusion criteria: previous treatment of H. Pylori infection; previous use of any antibiotics or bismuth subcitrate or any PPI or H2 blocker within four weeks prior to endoscopy; use of NSAIDs for more than four weeks; history of allergy to medications; previous history of any gastric surgery; underlying diseases such as cirrhosis or, uremia and pregnancy

排除标准

  • 未提供

研究者

发起方
Jundishapour Ahvaz Uuniversity of Medical Science

相似试验